A comparison of DNA damage induced by aflatoxin B1 in hepatocyte-like cells, their progenitor mesenchymal stem cells and CD34+ cells isolated from umbilical cord blood

被引:12
|
作者
Ghaderi, Masoumeh [1 ]
Allameh, Abdolamir [1 ]
Soleimani, Masoud [2 ]
Rastegar, Hossein [3 ]
Ahmadi-Ashtiani, Hamid Reza [1 ]
机构
[1] Tarbiat Modares Univ, Fac Med Sci, Dept Biochem, Tehran, Iran
[2] Tarbiat Modares Univ, Fac Med Sci, Dept Hematol, Tehran, Iran
[3] Minist Hlth & Med Educ, Food & Drug Control Lab, Tehran, Iran
关键词
Aflatoxin B1; Cytotoxicity; CYP3A4; Hepatocytes; Differentiation; Comet assay; Stem cell; BREAST-CANCER PATIENTS; BONE-MARROW; EXPRESSION; REPAIR; DIFFERENTIATION; ENZYMES; CYTOCHROME-P450; SENSITIVITY; APOPTOSIS; CULTURE;
D O I
10.1016/j.mrgentox.2010.09.005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This study compared the sensitivity of differentiated hepatocyte-like cells, their progenitor mesenchymal stem cells (MSCs) and CD34(+) stem cells to DNA damage and toxicity induced by aflatoxin B1 (AFB1). The hepatocyte-like cells and their progenitor cells (isolated from umbilical cord blood (UCB)) were each treated with AFB1 on day 15 of differentiation. Cell toxicity and genotoxicity effects were assessed using MTT and alkaline comet assays. AFB1 treatment resulted in a dose- and time-dependent inhibition of cell growth. The IC50 values of AFB1 for hepatocytes differentiated from CD34(+) and MSCs were within the same range (44.7-46.8 mu M). The IC50 calculated for non-differentiated MSCs and CD34(+) cells was slightly lower (42.0-43.4 mu M) than that calculated for their differentiated counterparts. However, the extent of DNA damage was different in differentiated and non-differentiated cells. The percentages of DNA (% DNA) in comet tails measured in hepatocytes differentiated from MSCs exposed to AFB1 (0, 2.5, 10 and 20 mu M) for 24h were similar to 15, 55,65 and 70%, respectively. In comparison, hepatocytes from CD34(+) cells were more resistant to AFB1-induced DNA damage. Hepatocyte-MSCs were most sensitive to DNA damage, followed by UCB-CD34(+) cells, then UCB-MSCs and finally hepatocyte-CD34(+) cells. These results clearly showed that stem cells from different sources have different sensitivities to DNA damaging agents. These differences can be assigned to the expression levels of cytochrome P450 (CYP) particularly CYP3A4 in non-differentiated and differentiated cells. These data are useful in better understanding the susceptibility/resistance of stem cells in the process of differentiation to environmental toxicants. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 50 条
  • [41] MESENCHYMAL STEM CELLS CONDITIONED MEDIA SUPPORTS THE GROWTH OF UMBILICAL CORD BLOOD ISOLATED ENDOTHELIAL PROGENITOR CELLS
    Kestendjieva, Snejana
    Popova, Zlatka
    Cvetkova, Gergana
    Bochev, Ivan
    Kehayov, Ivan
    Kyurkchiev, Stanimir
    Mourdjeva, Milena
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2009, 62 (06): : 739 - 744
  • [42] Expansion of human umbilical cord blood-derived CD34+ Stem/Progenitor cells to treat myocardial infarction
    Nagler, A
    Grynspan, F
    Peled, T
    Mandel, J
    Gutta, E
    Holbova, R
    Feinberg, M
    Leor, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 5 - 6
  • [43] Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells
    Delalat, Bahman
    Pourfathollah, Ali Akbar
    Soleimani, Masoud
    Mozdarani, Hossein
    Ghaemi, Soraya Rasi
    Movassaghpour, Ali Akbar
    Kaviani, Saeed
    HEMATOLOGY, 2009, 14 (03) : 125 - 132
  • [44] Ultrastructural features of CD34+ hematopoietic progenitor cells from bone marrow, peripheral blood and umbilical cord blood
    Deliliers, GL
    Caneva, L
    Fumiatti, R
    Servida, F
    Rebulla, P
    Lecchi, L
    De Harven, E
    Soligo, D
    LEUKEMIA & LYMPHOMA, 2001, 42 (04) : 699 - 708
  • [45] Comparison of nucleus pulposus stem/progenitor cells isolated from degenerated intervertebral discs with umbilical cord derived mesenchymal stem cells
    Wu, Hao
    Zeng, Xiaoli
    Yu, Jiayue
    Shang, Yupan
    Tu, Mei
    Cheang, Lek Hang
    Zhang, Jiaqing
    EXPERIMENTAL CELL RESEARCH, 2017, 361 (02) : 324 - 332
  • [46] Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media
    Shaw, PH
    Olszewski, M
    Kletzel, M
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (03): : 391 - 403
  • [47] Cytokine mediated expansion of human umbilical cord blood CD34+ cells: comparison of the use of partially purified and pure CD34+ target cells
    Case, J
    Rice, A
    Vowels, M
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (04) : 193 - 197
  • [48] Ex Vivo Expansion and Characterization of Human Umbilical Cord Blood CD34+ Stem Cells
    Zhang, Yu
    Shen, Bin
    Jiang, Wenhong
    Ren, Zhihua
    Dai, Wei
    Jiang, Yongping
    BLOOD, 2014, 124 (21)
  • [49] Ex vivo expansion of CD34+ cells from human umbilical cord blood and their cotransplantation with or without mesenchymal stem cells in irradiated BALB/C mice
    Pourfathollah, A. A.
    Delalat, B.
    Soleimani, M.
    Mozdarani, H.
    Movassaghpou, A. A.
    Ghaemi, S. Rasi
    Kavianie, S.
    Aghaei, Z.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 57 - 57
  • [50] Molecular analysis and comparison of CD34+ and CD133+ very small embryonic-like stem cells purified from umbilical cord blood
    Bujko, Kamila
    Ciechanowicz, Andrzej K.
    Kucia, Magdalena
    Ratajczak, Mariusz Z.
    CYTOMETRY PART A, 2023, 103 (09) : 703 - 711